New research suggests that a combination of lung-sparing surgery, highly targeted radiotherapy, and chemotherapy may bolster survival in people with malignant pleural mesothelioma. Researchers at Memorial Sloan Kettering Cancer Center in New York have just published some promising findings on trimodality mesothelioma treatment with hemithoracic intensity-modulated pleural radiotherapy (IMPRINT). Conventional RT vs IMPRINT The team analyzed the cases of 209 mesothelioma patients who underwent the … Continue reading Tri-Modality Treatment Extends Mesothelioma Survival
Peritoneal mesothelioma patients whose bodies produce too many blood platelets may not be good candidates for the treatment combination known as CRS with HIPEC. Cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) is a process for removing as much peritoneal mesothelioma from the abdomen as possible and killing any cancer cells left behind with a wash of heated medication. It has become the preferred … Continue reading Platelet Count Linked to Peritoneal Mesothelioma Survival After Surgery
New research out of Canada suggests that mesothelioma tumor thickness could be used to help predict mesothelioma survival and select the best treatments. Doctors at the University of Toronto compared the thickness of pleural mesothelioma tumors in 65 patients who had not yet received any treatment with their eventual outcomes and found a definite correlation. Summarizing their research in The European Respiratory Journal, the team … Continue reading Mesothelioma Tumor Thickness May Help Predict Treatment Outcomes
Immunotherapy is an important emerging therapeutic strategy for several types of cancer, but the jury is still out on whether it will eventually be a viable approach for malignant pleural mesothelioma. In a newly-published special report on the immune checkpoint inhibitor tremelimumab, researchers at the University of Salford in the UK call the use of such drugs “largely questionable” for pleural mesothelioma treatment. Their concerns, … Continue reading Immunotherapy for Pleural Mesothelioma: Does it Work?
Radical surgery and intensity modulated radiotherapy may lead to long-term survival for select pleural mesothelioma patients, but at what cost? That is the finding, and the question, raised by cancer researchers at Japan’s Kyoto University in a recent article published in the Swedish medical journal, Acta Oncologica. In their study of 21 pleural mesothelioma patients, intensity modulated radiotherapy (IMRT) after EPP surgery produced an overall … Continue reading Mesothelioma Patients See Long-Term Survival with EPP and IMRT
Pleural mesothelioma, a tumor that is notoriously resistant to even the most aggressive conventional cancer therapies, is being successfully treated at UCLA with extreme cold. The minimally invasive technique is called cryoablation or cryosurgery. Although it has been used in medicine for decades, UCLA is one of the few centers using cryoablation to treat mesothelioma tumors. The Challenge of Treating Mesothelioma Pleural mesothelioma, which grows … Continue reading Innovative Mesothelioma Treatment Uses Cold to Destroy Tumors
New research suggests that mesothelioma cells have the ability to form their own new blood vessels, potentially feeding the asbestos cancer’s aggressive growth. The news could lead to new treatments that specifically target this unique ability. Malignant mesothelioma is a cancer of the mesothelial linings around the lungs, heart or abdomen. It is caused almost exclusively by exposure to asbestos and is considered one of … Continue reading Mesothelioma Tumor Growth Discovery May Open Door to Novel Treatments
Doctors in Italy say they have found a way to perform a radical mesothelioma surgery called extrapleural pneumonectomy in a less-invasive way, potentially conferring many of the benefits with fewer risks. The team performed the new surgical technique at an Italian University hospital on a patient with early-stage malignant pleural mesothelioma. Radical Surgery for Pleural Mesothelioma Extrapleural pneumonectomy (EPP) is a large and traumatic operation, … Continue reading New Approach May Improve Safety of Controversial Mesothelioma Surgery
A large US study of mesothelioma patients confirms what other studies have suggested: Mesothelioma patients who have chemotherapy live longer than those who don’t, and multimodal therapy is the best way to improve overall mesothelioma survival. The study utilized data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) database and included 1,625 Medicare patients with a diagnosis or either peritoneal or pleural … Continue reading Study Finds Chemotherapy Maximizes Odds of Mesothelioma Survival
There has been some encouraging news this month for patients suffering from an aggressive form of lung cancer called malignant pleural mesothelioma. New research suggests that, even in patients with advanced mesothelioma, long-term survival is possible with a strategic multi-modal approach. The Research The new mesothelioma study, conducted at several US medical centers and published in the Annals of Thoracic Surgery, analyzed the survival rates … Continue reading Multi-Modal Mesothelioma Treatment Leads to Three-Year Survival
Get your free copy of
Surviving Mesothelioma Today!